<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: July 27th hearing on FRPAA: Who opposes public access to publicly funded research?</title>
	<atom:link href="http://openbiomed.info/2010/07/us-house-committee-to-hold-hearing-on-proposed-expanding-public-access-to-publicly-funded-research/feed/" rel="self" type="application/rss+xml" />
	<link>http://openbiomed.info/2010/07/us-house-committee-to-hold-hearing-on-proposed-expanding-public-access-to-publicly-funded-research/</link>
	<description>Accelerating access to biomedical evidence</description>
	<lastBuildDate>Sat, 04 Feb 2012 00:31:05 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Katie Newman</title>
		<link>http://openbiomed.info/2010/07/us-house-committee-to-hold-hearing-on-proposed-expanding-public-access-to-publicly-funded-research/comment-page-1/#comment-186</link>
		<dc:creator>Katie Newman</dc:creator>
		<pubDate>Thu, 22 Jul 2010 18:20:41 +0000</pubDate>
		<guid isPermaLink="false">http://openbiomed.info/?p=659#comment-186</guid>
		<description>According to the referenced DC Principles site, some of the publishers who oppose FRPAA were left off this listing ...
Royal College of Psychiatrists 
Society for Experimental Biology and Medicine 
Society of Nuclear Medicine 
Society for the Study of Reproduction 
Soil Science Society of America 
Springer Publishing Company 
Thieme Publishers 
University of Chicago Press 
Wolters Kluwer Health 

While in number the scholarly publishers may outnumber the commercial, I doubt that&#039;s true as far as the number of journals they publish -- Elsevier?  Wiley?  Springer?  etc.</description>
		<content:encoded><![CDATA[<p>According to the referenced DC Principles site, some of the publishers who oppose FRPAA were left off this listing &#8230;<br />
Royal College of Psychiatrists<br />
Society for Experimental Biology and Medicine<br />
Society of Nuclear Medicine<br />
Society for the Study of Reproduction<br />
Soil Science Society of America<br />
Springer Publishing Company<br />
Thieme Publishers<br />
University of Chicago Press<br />
Wolters Kluwer Health </p>
<p>While in number the scholarly publishers may outnumber the commercial, I doubt that&#8217;s true as far as the number of journals they publish &#8212; Elsevier?  Wiley?  Springer?  etc.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Bill would require public access to research : Covering Health</title>
		<link>http://openbiomed.info/2010/07/us-house-committee-to-hold-hearing-on-proposed-expanding-public-access-to-publicly-funded-research/comment-page-1/#comment-182</link>
		<dc:creator>Bill would require public access to research : Covering Health</dc:creator>
		<pubDate>Wed, 21 Jul 2010 20:27:15 +0000</pubDate>
		<guid isPermaLink="false">http://openbiomed.info/?p=659#comment-182</guid>
		<description>[...] 29 in the Rayburn House Office Building, room 2154. A list of organizations opposing the bill is at www.openbiomed.info, taken from a letter (PDF) to the Committee on Oversight and Government Reform. Doyle&#8217;s site [...]</description>
		<content:encoded><![CDATA[<p>[...] 29 in the Rayburn House Office Building, room 2154. A list of organizations opposing the bill is at <a href="http://www.openbiomed.info" rel="nofollow">http://www.openbiomed.info</a>, taken from a letter (PDF) to the Committee on Oversight and Government Reform. Doyle&#8217;s site [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: T Scott</title>
		<link>http://openbiomed.info/2010/07/us-house-committee-to-hold-hearing-on-proposed-expanding-public-access-to-publicly-funded-research/comment-page-1/#comment-180</link>
		<dc:creator>T Scott</dc:creator>
		<pubDate>Wed, 21 Jul 2010 14:46:00 +0000</pubDate>
		<guid isPermaLink="false">http://openbiomed.info/?p=659#comment-180</guid>
		<description>It should also be pointed out that most of the publishers that are listed under your heading &quot;Want to see the arguments that the commercial sector will take?&quot; are not-for-profit societies, not commercial publishers.</description>
		<content:encoded><![CDATA[<p>It should also be pointed out that most of the publishers that are listed under your heading &#8220;Want to see the arguments that the commercial sector will take?&#8221; are not-for-profit societies, not commercial publishers.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: T Scott</title>
		<link>http://openbiomed.info/2010/07/us-house-committee-to-hold-hearing-on-proposed-expanding-public-access-to-publicly-funded-research/comment-page-1/#comment-179</link>
		<dc:creator>T Scott</dc:creator>
		<pubDate>Wed, 21 Jul 2010 14:34:38 +0000</pubDate>
		<guid isPermaLink="false">http://openbiomed.info/?p=659#comment-179</guid>
		<description>The hearing is not specifically on FRPAA -- it is on the broader question of Public Access.  The signatories of the DC principles letter are not necessarily opposed to public access, they are opposed to FRPAA.  These are not the same thing.  The members of the Scholarly Publishing Roundtable are extremely supportive of public access, but the majority of us do not think that FRPAA, as currently drafted, is necessarily the best way to achieve that.  It is my hope that a broad range of issues will be discussed at the hearing and that what results will be something that does a better job of incorporating the principles of the Scholarly Publishing Roundtable report than the current draft of FRPAA does.</description>
		<content:encoded><![CDATA[<p>The hearing is not specifically on FRPAA &#8212; it is on the broader question of Public Access.  The signatories of the DC principles letter are not necessarily opposed to public access, they are opposed to FRPAA.  These are not the same thing.  The members of the Scholarly Publishing Roundtable are extremely supportive of public access, but the majority of us do not think that FRPAA, as currently drafted, is necessarily the best way to achieve that.  It is my hope that a broad range of issues will be discussed at the hearing and that what results will be something that does a better job of incorporating the principles of the Scholarly Publishing Roundtable report than the current draft of FRPAA does.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

